Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-39.67%
20241.32%
2023-4.51%
2022-5.50%
202140.64%
2020181.84%
2019287.87%
2018193.39%
20170.00%